Bloom Energy stock jumps as $600 million Wells Fargo credit line and $502 million Quanta microgrid deal draw fresh attention

Bloom Energy stock jumps as $600 million Wells Fargo credit line and $502 million Quanta microgrid deal draw fresh attention

NEW YORK, Jan 7, 2026, 11:43 EST — Regular session

  • Bloom Energy shares were up about 8% in late morning trade, after an early dip below $101
  • Traders pointed to late-December disclosures on a new bank facility and a large Quanta microgrid purchase
  • Next catalyst: Bloom’s Feb. 5 earnings report and any update on delivery timing and cash use

Bloom Energy Corp (NYSE: BE) shares rose 8.1% to $111.38 on Wednesday, lifting off an intraday low of $100.87, as investors refocused on a new $600 million bank line and a large fuel-cell microgrid purchase linked to Quanta. The stock hit an intraday high of $111.41 and traded more than 8.3 million shares by late morning, keeping the $100 level in play for traders after the early slide.

The move matters because Bloom has become a sensitive read-through on on-site power demand, a corner of the market that has drawn attention as data centers and factories run into grid delays. When the story is about speed — getting power on the ground — liquidity and order size can move the shares as much as the broader tape.

In plain terms, investors are watching two things at once: whether customers are placing big checks for equipment, and whether Bloom has enough financial room to build and deliver it without straining its balance sheet. That mix can make the stock swing hard on filings and contract chatter.

In an SEC filing, Bloom said it entered into a credit agreement with Wells Fargo Bank, National Association and other lenders that provides a $600 million senior secured multicurrency revolving credit facility — a bank line the company can draw and repay as needed. The facility matures in December 2030, and Bloom said proceeds may be used for working capital, capital expenditures and other general corporate purposes. 1

Quanta Computer disclosed on Dec. 30 that its subsidiary QMN (Quanta Manufacturing Nashville LLC) would acquire three fuel cell microgrid systems in California from Bloom Energy for about $502.154 million, including installation and technical support — a microgrid is a power system that can run a site with less reliance on the utility grid. The filing listed Bloom Energy as the counterparty and broke the total out by site, including about $223.177 million for plant B18.

Bloom’s gains came even as other fuel-cell stocks slid. Plug Power fell about 4.8% and FuelCell Energy dropped about 7.5% on the day.

But the financing also comes with strings that investors tend to price in late. The revolving facility is secured and includes financial covenants — leverage and interest-coverage tests — and non-compliance could make the debt due sooner, according to S&P Capital IQ’s summary of the agreement. 2

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target
Previous Story

Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next
Next Story

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Go toTop